Plant-Based Viruses Could Revolutionize Martian Medicine Production

The logistical hurdles of establishing a human presence on Mars include the critical need for reliable access to medicine. Traditional pharmaceuticals degrade significantly faster in the harsh conditions of space, with studies on the International Space Station (ISS) showing many drugs losing efficacy within three years. This poses a major challenge for extended stays on the Red Planet, where resupply missions are infrequent and costly.

A promising solution is emerging from the University of California San Diego, where researchers are developing a method to cultivate medicines directly on Mars using plants. This innovative approach leverages genetically engineered viruses as biological factories within plant cells.

The Plant as a Pharmacy

The core of this research lies in utilizing viruses that infect plants to produce pharmaceutical compounds. While this technique is already employed on Earth, traditional methods often require large, complex equipment for extraction, making them impractical for extraterrestrial missions.

The UC San Diego team has devised a way to overcome this limitation. They are directing the production of therapeutic proteins to a specific compartment within plant leaves known as the apoplast. This allows for the extraction of the desired compounds without destroying the plant or requiring extensive machinery, a crucial factor for space-based operations.

The development is particularly significant as plants themselves can serve multiple functions in a Martian habitat, including recycling air and water, further enhancing their value.

Addressing Drug Degradation

Experiments aboard the ISS have revealed that a substantial portion of medications, including antibiotics like amoxicillin and levofloxacino, as well as chronic disease treatments such as levothyroxine, degrade rapidly under space conditions. Common pain relievers and anti-inflammatories like aspirin and ibuprofen, and antihistamines like loratadine, have also shown reduced shelf life. These are all vital medications for long-duration missions.

The plant-based production method aims to create these essential drugs on-demand, mitigating the risk associated with long-term storage and transport of pre-packaged pharmaceuticals.

Viral Vectors and Plant Hosts

The scientists are employing a modified version of the cowpea mosaic virus, known for its ability to infect plants and, in some research contexts, stimulate immune responses. For this study, they are using Nicotiana benthamiana plants, which are known for their rapid growth and ability to produce substantial biomass, facilitating high yields of viral particles and subsequent medicinal compounds.

While not all medications are derived from viruses, the engineered viruses are designed to instruct the plant cells to synthesize specific therapeutic proteins. This effectively transforms the plant into a factory for a desired medicine.

Simplified Extraction Process

The key innovation is the simplified extraction protocol. After the plants produce the medicinal proteins within the apoplast, the leaves are immersed in a buffer solution. This mixture is then placed in a sealed container where a vacuum is applied. This process encourages the buffer solution within the leaves to flow into the apoplast, carrying the extracted proteins with it.

Following this, the leaves are centrifuged, separating the apoplast fluid containing the pharmaceuticals from the plant material. This fluid can then be processed to isolate the final drug.

Simulated Space Conditions Tested

The extraction process has been successfully demonstrated on Earth with over 50 plants in under two hours. Crucially, many of these plants were subjected to simulated space conditions, including microgravity, temperature fluctuations, and oxidative stress. The results were encouraging, with the process showing no adverse effects and, in some cases, improved performance under oxidative stress, as the viruses may target stressed organisms more effectively.

While further research is necessary, this development represents a significant step towards enabling self-sufficient pharmaceutical production for future Martian explorers.

Key facts
| Aspect | Detail |
|—|—|
| Challenge | Degradation of medicines in space |
| Solution | Plant-based pharmaceutical production using engineered viruses |
| Location | University of California San Diego |
| Target Environment | Mars colonization missions |
| Extraction Method | Apoplast extraction without plant destruction |
| Tested Conditions | Simulated microgravity, temperature fluctuations, oxidative stress |

This advancement is directly relevant to the ReviewArticle audience by highlighting cutting-edge AI and biotechnology applications in critical fields like space exploration. It showcases how scientific ingenuity, potentially enhanced by AI-driven research and development, can solve complex logistical and survival challenges for future human endeavors beyond Earth.

Source: Resolviendo uno de los mayores retos logísticos de colonizar Marte: la caducidad de los medicamentos – Xataka – https://www.xataka.com/espacio/virus-que-infecta-plantas-podria-convertirse-farmacia-astronautas-marte

Datos clave